Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;8(2):738-740.
doi: 10.4103/jfmpc.jfmpc_468_18.

Relationship between serum procalcitonin level and chronic obstructive pulmonary disease

Hamid Borsi  1 , Elham Pajohan Nia  2 , Mehrdad Dargahi Mal-Amir  3 , Hanieh Raji  1
Affiliations

Relationship between serum procalcitonin level and chronic obstructive pulmonary disease

Hamid Borsi et al. J Family Med Prim Care. 2019 Feb.

Abstract

Background: Differentiation of the etiologies of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and differential diagnosis of other causes of respiratory attacks in chronic obstructive pulmonary disease (COPD) patients are challenging. Serum procalcitonin (PCT) which is a biomarker of bacterial infection, but not viral infections, could possibly recognize AECOPD requiring antibiotic treatment from other etiologies of respiratory attack.

Methods: Patients aged from 40-80 years who were diagnosed with COPD according to the GOLD criteria and who referred to the Imam Khomeini Hospital of Ahvaz in 2016 were divided into two groups of exacerbated and stable COPD. Exacerbation of COPD is defined as worsening of the patient's condition from the stable state and behind normal day-to-day variations that is acute in onset and may necessitate treatment in a patient with underlying COPD. BODE Index and 6MWDT were used to assess the patients, and the severity of their disease was determined based on the GOLD criteria. Subsequently, PCT testing using electrochemiluminescence (ECL) method was carried out on patients on the same day.

Results: PCT level in the exacerbation group was 0.272 ± 0.586 and 0.066 ± 0.027 in the non-exacerbation group, and their difference was statistically significant with P value = 0.001. Based on the results, the cut point of differentiating between the AECOPD and the stable groups with a sensitivity of 68% and a specificity of 80% is 0.085.

Conclusion: Overall, the findings of this study indicate that PCT levels could be regarded as a good diagnostic marker for patients with COPD, and for the differentiation of AECOPD patients from stable COPD patients.

Keywords: Biomarker; chronic obstructive pulmonary disease; procalcitonin.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Difference between the AECOPD group and the stable group
See this image and copyright information in PMC

References

    1. Pazarli AC, Koseoglu HI, Doruk S, Sahin S, Etikan I, Celikel S, et al. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation? J Res Med Sci. 2012;17:1047–51. - PMC - PubMed
    1. Wedzicha JA. Exacerbations: Etiology and pathophysiologic mechanisms. Chest. 2002;121:136S–41S. - PMC - PubMed
    1. Mohamed KH, Abderabo MM, Ramadan ES, Hashim MM, Sharaf SM. Procalcitonin as a diagnostic marker in acute exacerbation of COPD. Egyptian J Chest Dis Tuberc. 2012;61:301–5.
    1. Carrol Ed, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;20:1–9. - PubMed
    1. Thai KT, Chan ES, Ling KL, Ng WY, Jacob E, Ooi CJ. Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease. Dig Dis Sci. 2008;53:2960–8. - PubMed